Exact Sciences Partners with Carlos Ponce to Boost Colorectal Cancer Awareness in the Hispanic Community

Merck Receives Positive CHMP Opinion for KEYTRUDA® in Combination Therapy for First-Line Treatment of Non-Epithelioid Mesothelioma

Australia Launches Genomics Australia to Lead Advances in Genomic Medicine

Sidra Medicine Unveils Masterclasses Ahead of PMFG 2024 Summit

FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

CHMP Recommends Approval of Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

ADDF Invests $1.18M to Standardize p-tau217 Blood Tests for Alzheimer’s Diagnosis

GSK Reports Positive Interim Results for DREAMM-7 Trial of Blenrep in Multiple Myeloma

Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Home
/
insight
/
details

Flow cytometry a valuable tool for tailoring immunotherapy

NextEdge Admin

08 Sep 2023

4 min 15 sec

Flow cytometry is a valuable tool for tailoring immunotherapy, particularly in the context of cancer treatment. It helps analyze the patient’s immune system, which is crucial for the development and optimization of personalized immunotherapy strategies, such as CAR-T cell therapy. Here’s how flow cytometry is used to tailor immunotherapy:

Immunophenotyping: Flow cytometry is used to characterize the patient’s immune cells, including T cells, B cells, natural killer cells, and other immune cell subsets. By assessing the composition and activation status of these cells, healthcare providers can identify the patient’s immune profile.
Identification of Tumor Antigens: Flow cytometry can be employed to identify specific antigens expressed on the surface of tumor cells. This information is essential for selecting the most suitable targets for immunotherapy, like CAR-T cell therapy.
T Cell Function and Activation: Flow cytometry helps assess the functionality and activation status of the patient’s T cells. This information is crucial for determining whether the patient’s T cells are responsive to the tumor-specific antigens and if they need any modifications or activation for effective immunotherapy.
Immune Checkpoint Inhibition: Flow cytometry can be used to evaluate the expression of immune checkpoint molecules like PD-1 and CTLA-4 on T cells. This information is vital for deciding whether checkpoint inhibitors like PD-1/PD-L1 or CTLA-4 blockade therapies would be effective.
Cytokine Profiling: Flow cytometry can measure cytokine production by immune cells. Cytokines play a significant role in the regulation of immune responses, and assessing their production can help in understanding the patient’s immune status.
Minimal Residual Disease Monitoring: Flow cytometry is used to monitor the persistence of cancer cells in the patient’s body after immunotherapy. Detecting minimal residual disease is critical for tracking the effectiveness of treatment and deciding whether further interventions are necessary.
Patient Stratification: In clinical trials and research, flow cytometry is used to stratify patients into different groups based on their immune profiles. This allows for more precise selection of immunotherapy options and can improve treatment outcomes.
Response Monitoring: During the course of immunotherapy, flow cytometry is used to monitor the patient’s immune response and assess the impact of treatment on the immune system and tumor.

By combining the information gathered through flow cytometry with other clinical and genetic data, healthcare providers can develop tailored immunotherapy strategies for cancer patients. This approach maximizes the chances of a successful response to treatment while minimizing the risk of adverse effects, as the treatment is designed to target the patient’s specific immune and tumor characteristics.

Related Tags

immunotherapy

tailoring

What is Pharmacogenomics (PGx) and pharmacogenetics?

Utilization of Immune Checkpoints in Precision Oncology

Top Reviews

No reviews yet